Scientific Advisory Board
Dr Federica Sotgia
Federica obtained her PhD in Medical Genetics in 2001 from the University of Genova, Italy. She then moved to Albert Einstein College of Medicine, New York, as a post-doctoral fellow, where she was promoted to Instructor. In 2006, she was appointed as an Assistant Professor in the Department of Cancer Biology at the Kimmel Cancer Center, Thomas Jefferson University, in Philadelphia. In September 2012, she started her new role at the University of Manchester as a Senior Lecturer. She has a background in skeletal muscle biology and mitochondrial oxidative phosphorylation.
As a PhD student, she was the first to discover that mutations in the caveolin-3 gene are the cause of a novel form of limb-girdle muscular dystrophy, named LGMD-1C. Later on in my career, she developed an interest in breast cancer, and she has applied the knowledge and expertise gained from studying mitochondrial metabolism to the breast cancer field.
Dr Federica SotgiaProfessor; Biomedical Research Centre; University of Salford (non‐voting member)
Dr Clare Conlon
Clare graduated as a doctor from the University of Edinburgh Medical School in 2003 and began her training in anaesthetics becoming a Fellow of the Royal College of Anaesthetists in 2008.
Bachelor of Medicine and Surgery awarded from University of Edinburgh Medical School
Fellow of the Royal College of Anaesthetists
‘Like all of us I want to protect my health and health of my family and there was nothing more important than this when my mother was diagnosed with Breast Cancer in 2008.
I have often wondered when we as a society are going to become more powerful in battling against the very high occurrence of degenerative diseases such as cancer, Alzheimer’s and diabetes and I am delighted to be involved in such ground breaking research.’
Dr Clare ConlonConsultant Anaesthetist Manchester Royal Infirmary
Professor Michael Lisanti
An active research scientist for more than three decades with a broad background in cell biology and genetics, Professor Lisanti graduated with a degree in Chemistry (Magna Cum Laude) from New York University and obtained his MD-PhD at Cornell University Medical School in Cell Biology and Genetics. From 1992-96, he was a Skeggs Fellow at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology (MIT), followed by several distinguished appointments at the Albert Einstein College of Medicine and the Kimmel Cancer Centre. Professor Lisanti joined the Breakthrough Unit in 2012 as Professor of Cancer Biology. He is currently listed amongst the Top 100 Most-Cited Researchers in Biochemistry and Biology. He has an H-index >140, with over 70,000 citations. Moreover, he has published > 530 papers and is the former Editor-in-Chief of The American Journal of Pathology.